tiprankstipranks
Palisade Bio (PALI)
NASDAQ:PALI
US Market

Palisade Bio (PALI) Stock Forecast & Price Target

Compare
516 Followers
See the Price Targets and Ratings of:

PALI Financial Forecast

PALI Earnings Forecast

Next quarter’s earnings estimate for PALI is -$2.58 with a range of -$2.76 to -$2.39. The previous quarter’s EPS was -$2.32. PALI beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.36% of the time in the same period. In the last calendar year PALI has Outperformed its overall industry.
Next quarter’s earnings estimate for PALI is -$2.58 with a range of -$2.76 to -$2.39. The previous quarter’s EPS was -$2.32. PALI beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.36% of the time in the same period. In the last calendar year PALI has Outperformed its overall industry.

PALI Sales Forecast

Next quarter’s sales forecast for PALI is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PALI beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.54% of the time in the same period. In the last calendar year PALI has Preformed in-line its overall industry.
Next quarter’s sales forecast for PALI is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PALI beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.54% of the time in the same period. In the last calendar year PALI has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group
$8
Buy
863.86%
Upside
Reiterated
12/03/24
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), Evolent Health (NYSE: EVH) and Palisade Bio (NASDAQ: PALI)
Brookline Capital Markets
$38
Buy
4478.31%
Upside
Initiated
11/20/24
Palisade Bio initiated with a Buy at BrooklinePalisade Bio initiated with a Buy at Brookline
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Palisade Bio

Which Analyst Should I Follow If I Want to Buy PALI and Sell After:
1 Month
xxx
Success Rate
3/15 ratings generated profit
20%
Average Return
-12.65%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 20.00% of your transactions generating a profit, with an average return of -12.65% per trade.
3 Months
xxx
Success Rate
0/15 ratings generated profit
0%
Average Return
-42.64%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -42.64% per trade.
1 Year
Naz RahmanMaxim Group
Success Rate
0/15 ratings generated profit
0%
Average Return
-78.13%
reiterated a buy rating 3 months ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -78.13% per trade.
2 Years
xxx
Success Rate
0/15 ratings generated profit
0%
Average Return
-79.79%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -79.79% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PALI Analyst Recommendation Trends

Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
4
4
3
4
4
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
3
4
4
In the current month, PALI has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PALI average Analyst price target in the past 3 months is $8.00.
Each month's total comprises the sum of three months' worth of ratings.

PALI Stock Forecast FAQ

What is PALI’s average 12-month price target, according to analysts?
Based on analyst ratings, Palisade Bio’s 12-month average price target is $8.00.
    What is PALI’s upside potential, based on the analysts’ average price target?
    Palisade Bio has 863.86% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PALI a Buy, Sell or Hold?
          Palisade Bio has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Palisade Bio’s price target?
            The average price target for Palisade Bio is $8.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 863.86% Increase from the current price of $0.83.
              What do analysts say about Palisade Bio?
              Palisade Bio’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of PALI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis